| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 35,157 | 30,506 | 29,118 | 27,531 | | Cost of Revenue | 6,246 | 6,398 | 6,899 | 6,759 | | | Gross Profit | 28,911 | 24,108 | 22,219 | 20,772 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 14,032 | 11,544 | 9,599 | 9,128 | | Non Recurring | 250 | (250) | 250 |
-
| | Others | 3,638 | 768 | 964 | 4,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 10,991 | 12,046 | 11,406 | 7,644 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 10,991 | 12,046 | 11,406 | 7,644 | | Interest Expense | 4,093 | 4,354 | 5,474 | 5,999 | | Income Before Tax | 6,898 | 7,692 | 5,932 | 1,645 | | Income Tax Expense | 2,656 | 2,961 | 2,284 | 634 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,242 | 4,731 | 3,648 | 1,011 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,242 | 4,731 | 3,648 | 1,011 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,242 | $4,731 | $3,648 | $1,011 |
|
1.23% Nasdaq 0.00%
Income Statement
